The Stem Cell sector is, still considered a voodoo medicine by Investors. Indeed, it has failed to generate even one credible treatment, although it did generate some mind boggling value destruction for investors.
But this is about to change.
Within 2 years I believe we will see some actual Stem Cell Regenerative treatments reaching P.3, resolving crippling conditions and pulling in massive revenues.
At that time credibility will return. The best companies will see a lot of demand for shares.
Biotime, IMHO, is the top asset in the whole field. It controls a ton of IP and has its fingers in many pies.
I like to think of BTX as the Intel of Stem Cell.
The CEO practically pioneered the research into Stem Cell.
It's miles ahead of everyone else, and it's financing record, for non profit corp. are second to none.
The Board is practically majority shareholders.
But there is still some time to the big changes.
So, this is a ten year game. Buy now and you will be considered a genius in 10 years.
But you'll have to wait.
Waiting is hard, even when value is created every quarter in the lab.
That why most people don't do well in the stock exchange.
Btx can easily be a large cap company. There is so much to do in this sector, and so little doing it.
Heck. Asterias (sub) is practically turning fully crippled people to people who can be self reliant. That has never occurred before.
Sit tight and observe the building of a industry titan.
News 
Market Data 
Discover 
